|Bid||15.25 x 800|
|Ask||18.45 x 1800|
|Day's Range||15.17 - 15.99|
|52 Week Range||12.48 - 32.30|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 03, 2022 - Aug 08, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||29.25|
Subscribe to Yahoo Finance Plus to view Fair Value for TMCI
Treace Medical Concepts (TMCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Since it was founded in 2014, Treace Medical Concepts, Inc. (NASDAQ: TMCI) has been pursuing dominance in a niche market that it believes is untapped and underserved. “Some companies grow by offering everything to everyone,” said Mark Hair, chief financial officer of the Ponte Vedra Beach-based orthopedic medical device company. “We are really, truly focused on the bunion and concomitant issues in the foot.”
Whilst it may not be a huge deal, we thought it was good to see that the Treace Medical Concepts, Inc. ( NASDAQ:TMCI...